Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
European Journal of Pharmacology|February 22, 1996
Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampusR A Wright, D D Schoepp
Biochemical Pharmacology|August 1, 1985
Comparison of postnatal changes in alpha 1-adrenoceptor binding and adrenergic stimulation of phosphoinositide hydrolysis in rat cerebral cortexD D Schoepp, C O Rutledge
Journal of Neurochemistry|June 1, 1985
Further studies on the nature of postsynaptic dopamine uptake and metabolism in rat striatum: sodium dependency and investigation of a possible role for carrier-mediated uptake into serotonin neuronsD D Schoepp, A J Azzaro
Neurochemistry International|May 28, 2010
In vivo 2-amino-3-phosphonopropionic acid administration to neonatal rats selectively inhibits metabotropic excitatory amino acid receptors ex vivo in brain slicesD D Schoepp, B G Johnson
Journal of Neurochemistry|August 1, 1981
Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibitionD D Schoepp, A J Azzaro
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in ratsJ Cartmell, J A Monn, D D Schoepp
European Journal of Pharmacology|September 16, 2000
The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearingJ Cartmell, J A Monn, D D Schoepp
Psychopharmacology|August 6, 2000
Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapineJ Cartmell, J A Monn, D D Schoepp
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 29, 2000
Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268J Cartmell, J A Monn, D D Schoepp
Neuroscience Letters|July 4, 1997
In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in ratsG Battaglia, J A Monn, D D Schoepp
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Pharmacology|February 22, 1996
Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampusR A Wright, D D Schoepp
Biochemical Pharmacology|August 1, 1985
Comparison of postnatal changes in alpha 1-adrenoceptor binding and adrenergic stimulation of phosphoinositide hydrolysis in rat cerebral cortexD D Schoepp, C O Rutledge
Journal of Neurochemistry|June 1, 1985
Further studies on the nature of postsynaptic dopamine uptake and metabolism in rat striatum: sodium dependency and investigation of a possible role for carrier-mediated uptake into serotonin neuronsD D Schoepp, A J Azzaro
Neurochemistry International|May 28, 2010
In vivo 2-amino-3-phosphonopropionic acid administration to neonatal rats selectively inhibits metabotropic excitatory amino acid receptors ex vivo in brain slicesD D Schoepp, B G Johnson
Journal of Neurochemistry|August 1, 1981
Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibitionD D Schoepp, A J Azzaro
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in ratsJ Cartmell, J A Monn, D D Schoepp
European Journal of Pharmacology|September 16, 2000
The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearingJ Cartmell, J A Monn, D D Schoepp
Psychopharmacology|August 6, 2000
Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapineJ Cartmell, J A Monn, D D Schoepp
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 29, 2000
Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268J Cartmell, J A Monn, D D Schoepp
Neuroscience Letters|July 4, 1997
In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in ratsG Battaglia, J A Monn, D D Schoepp
Pageof 13